Dec 12, 2018 7:35am EST NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder
Dec 11, 2018 4:10pm EST NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
Nov 30, 2018 5:01pm EST QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
